Abstract:BackgroundResveratrol, a natural, polyphenolic stilbene, is reported to be a potential promoter of metabolic health and longevity. Piceatannol is a natural, structural analog of resveratrol that putatively shares a similar function. Previous studies on piceatannol provide evidence of anti‐inflammatory and anti‐cancer properties. However, the distinct functional role of piceatannol in cell and energy metabolism is unclear.ObjectiveWe hypothesized that piceatannol and resveratrol would exhibit differential proteomic profiles. Thus, the objective of this study was to identify potential target proteins of piceatannol and resveratrol within the proteomic profile of Caenorhabditis elegans.MethodsC. elegans were treated with piceatannol, resveratrol, or a vehicle for 3 days. Samples were digested with trypsin to be separated on a strong cation exchange column, concentrated on a C18 enrichment column, separated on an analytical C18 reversed‐phase column, and eluted through nanoelectrospray ion trap for MS/MS analysis. Resulting MS/MS data were analyzed using MaxQuant. Proteins were identified using the Uniprot database. To account for otherwise excluded proteins in statistical analyses, we set inclusion parameters for absent data points. We used STRING and DAVID databases to perform functional enrichment analysis on identified proteins.ResultsWe identified 1292 total proteins in the C. elegans proteome. Compared to the vehicle‐treated control, piceatannol treatment produced 40 differentially expressed proteins while resveratrol treatment altered 37 proteins (paired t‐test, p<0.05). These proteins were further subjected to functional enrichment analysis on KEGG pathways to identify potential cellular function. Metabolic pathways and oxidative phosphorylation were common to both treatments. In addition, piceatannol treatment modulated proteasome proteins while resveratrol treatment modulated proteins involved carbon metabolism, propanoate metabolism, and citrate cycle. Using the Tukey method for paired comparisons (alpha=.05) in one‐way ANOVA, we found that 10 proteins were expressed differently by piceatannol and 4 proteins were expressed differently by resveratrol.ConclusionThese results provide evidence that piceatannol induces a distinct functional response from resveratrol in C. elegans. These results also suggest that piceatannol modulates proteasome function while resveratrol imparts more influence on energy and substrate metabolism, although further study is necessary to confirm these findings. Identification of differentially expressed proteins provides new insights into the potential mechanistic actions of piceatannol on regulating metabolism.Support or Funding InformationCore Pilot Funding from Indiana Clinical and Translational Sciences Institute (UL1TR001108)

Biotransformation of Piceatannol, a Dietary Resveratrol Derivative: Promises to Human Health.

Phase I Metabolism of Pterostilbene, a Dietary Resveratrol Derivative: Metabolite Identification, Species Differences, Isozyme Contribution, and Further Bioactivation.

Exploration of Nutraceutical Potentials of Isorhapontigenin, Oxyresveratrol and Pterostilbene: A Metabolomic Approach

Piceatannol Alleviates Glucolipotoxicity Induced Vascular Barrier Injury Through Inhibition of the ROS/NF-kappa B Signaling Pathway.

Impact of Piceatannol and Resveratrol on the Proteomic Profile of Caenorhabditis Elegans

Modification of the 4-Hydroxyphenylacetate-3-hydroxylase Substrate Pocket to Increase Activity towards Resveratrol

Resveratrol Derivatives As Promising Chemopreventive Agents with Improved Potency and Selectivity.

Piceatannol Upregulates SIRT1 Expression in Skeletal Muscle Cells and in Human Whole Blood: In Vitro Assay and a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial

Quantification of Pinosylvin in Rat Plasma by Liquid Chromatography–tandem Mass Spectrometry: Application to a Pre-Clinical Pharmacokinetic Study

Microbial biotransformation to obtain stilbene methylglucoside with GPR119 agonistic activity

The Metabolic Characteristics and Bioavailability of Resveratrol Based on Metabolic Enzymes

Comparision of Piceid and Resveratrol in Antioxidation and Antiproliferation Activities in Vitro

New Insights into Dietary Pterostilbene: Sources, Metabolism, and Health Promotion Effects

Characterization of metabolic features and potential anti-osteoporosis mechanism of pinoresinol diglucoside using metabolite profiling and network pharmacology

Pharmacokinetics and Tissue Distribution Study of Pinosylvin in Rats by Ultra-High-Performance Liquid Chromatography Coupled with Linear Trap Quadrupole Orbitrap Mass Spectrometry

Biotransformation of Piceid in Polygonum Cuspidatum to Resveratrol by Aspergillus Oryzae

A mechanism underlying the anti‐inflammatory action of piceatannol

Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans

Comprehensive analysis of resveratrol metabolites in rats using ultra high performance liquid chromatography coupled with high resolution mass spectrometry

Dose-dependent Absorption and Metabolism of Trans-Polydatin in Rats.

Biosynthesis of Piceatannol from Resveratrol in Grapevine Can Be Mediated by Cresolase-Dependent Ortho-Hydroxylation Activity of Polyphenol Oxidase